Growth Metrics

TransMedics (TMDX) Return on Capital Employed (2019 - 2026)

TransMedics' quarterly Return on Capital Employed came in at 8.14% in Q1 2026, up 128.0% year-on-year from 3.57% in Q1 2025, and down 31.16% quarter-over-quarter from 11.83% in Q4 2025.

TransMedics has reported Return on Capital Employed for 8 years, with the latest figure at 8.14% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 128.0% year-over-year to 8.14%; the trailing twelve-month figure through Mar 2026 stood at 8.14% (up 128.0% YoY), and the FY2025 full-year result was 12.82%, up 743.0% from the prior year.
  • Return on Capital Employed for Q1 2026 stood at 8.14%, down from 11.83% in the prior quarter.
  • The five-year high for Return on Capital Employed was 11.83% in Q4 2025, with the low at 43.07% in Q2 2022.
  • Average Return on Capital Employed over 5 years is 4.89%, with a median of 2.14% recorded in 2024.
  • Year-over-year, Return on Capital Employed slumped 2208 bps in 2022 and surged 3972 bps in 2023.
  • Tracing TMDX's Return on Capital Employed over 5 years: stood at 12.46% in 2022, then surged by 64 bps to 4.47% in 2023, then surged by 214 bps to 5.1% in 2024, then jumped by 132 bps to 11.83% in 2025, then sank by 31 bps to 8.14% in 2026.
  • The last three Return on Capital Employed figures came in at 8.14% (Q1 2026), 11.83% (Q4 2025), and 11.44% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.61%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 12.24%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 7.36%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 11.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 7.62%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 24.24%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 9.30%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 11.57%
10 TransMedics 2.32 Bn 1.86 Bn 101.16 Mn 8.14%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 8.14%
Dec 31, 2025 11.83%
Sep 30, 2025 11.44%
Jun 30, 2025 9.48%
Mar 31, 2025 6.86%
Dec 31, 2024 5.10%
Sep 30, 2024 4.42%
Jun 30, 2024 -0.12%
Mar 31, 2024 -2.14%
Dec 31, 2023 -4.47%
Sep 30, 2023 -5.95%
Jun 30, 2023 -3.35%
Mar 31, 2023 -9.53%
Dec 31, 2022 -12.46%
Sep 30, 2022 -20.52%
Jun 30, 2022 -43.07%
Mar 31, 2022 -38.73%
Dec 31, 2021 -35.91%
Sep 30, 2021 -28.35%
Jun 30, 2021 -20.99%
Mar 31, 2021 -18.14%
Dec 31, 2020 -18.35%
Mar 31, 2020 -36.78%
Dec 28, 2019 -31.88%
Sep 28, 2019 -26.69%
Jun 29, 2019 -37.15%
Mar 30, 2019 -88.30%